Author:
Feng Xiao-Yan,Jia Wen-Qing,Liu Xin,Jing Zhi,Liu Ya-Ya,Xu Wei-Ren,Cheng Xian-Chao
Funder
Natural Science Foundation of Tianjin#1
Opening Project of Shanghai Key Laboratory of New Drug Design#2
National Natural Science Foundation of China#3
China Postdoctoral Science Foundation#4
Subject
Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology
Reference44 articles.
1. Molecular docking reveals the potential of phthalate esters to inhibit the enzymes of the glucocorticoid biosynthesis pathway;Ahmad;J. Appl. Toxicol.,2017
2. Peroxisome proliferator-activated receptor (PPAR)beta/delta, a possible nexus of PPARalpha- and PPARgamma-dependent molecular pathways in neurodegenerative diseases: review and novel hypotheses;Aleshin;Neurochem. Int.,2013
3. Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) inhibitors;Baby;Bioinformation,2016
4. Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes;Benardeau;Bioorg. Med. Chem. Lett.,2009
5. PPAR agonists, - Could tissue targeting pave the way?;Bugge;Biochimie,2017
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献